Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Summary by Ground News
ProPhase Labs, Inc. (PRPH) is one of 1184 individual stocks in the Medical sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Consensus Estimate for PRPH's full-year earnings has moved 107.6% higher within the past quarter.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Zacks Investment ResearchZacks Investment Research

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Here is how ProPhase Labs, Inc. (PRPH) and RVL Pharmaceuticals PLC (RVLP) have performed compared to their sector so far this year.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Zacks Investment Research broke the news on Thursday, May 26, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal